Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

Fig. 3

Matrix model of the proportion of patients in remission or low disease activity by CDAI at week 24/30 based on baseline SJC28, CRP, and PhGA. Data are presented as % (95% confidence interval). Predicted probability of patients in remission or low disease activity represented by shading: green, > 47.0%; yellow, 40.0–47.0%; red, < 40.0%. CDAI, Clinical Disease Activity Index; CRP, C-reactive protein; PhGA, physician global assessment; SJC28, 28 swollen joint count; VAS, visual analogue scale

Back to article page